Has Timothy Kwiecien, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,767 in general payments to Timothy Kwiecien, MD across 339 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Kwiecien, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Kwiecien, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Kwiecien, MD

Anesthesiology · Marshall, MINPI 1780071340

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 25.9% of the total. Among anesthesiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,767in general payments, 2019–2025

Across 339 payments — averaging $78.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$7K
Boston Scientific$6K
Nevro Corp.$4K
Medtronic$4K
Si-bone, Inc.$2K
Spinal Simplicity, LLC$1K
plus $3K from 7 others

What the payments were for

Grants$750%
Travel & lodging$11,07041%
Food & beverage$15,62258%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	122	$6,944
Boston Scientific	61	$5,597
Nevro Corp.	55	$4,401
Medtronic(2 entities)	38	$4,006
Si-bone, Inc.	13	$1,794
Spinal Simplicity, LLC	12	$1,486
Curonix LLC	6	$850
Stryker	6	$504
Globus Medical	18	$484
SPR Therapeutics, Inc	4	$284
Relievant Medsystems, Inc.	2	$242
Johnson & Johnson	1	$95
Nalu Medical, Inc.	1	$81

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza Spinal Cord Stimulation System$2,710
OCTRODE$1,664
SYNCHROMEDII$1,492
HA MINUTEMAN G3-R$1,295
IFUSE IMPLANT SYSTEM$1,238
GENERAL - THERAPIES$1,215
WAVEWRITER ALPHA$1,093
Proclaim IPG$1,038
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$752
INTELLIS$713
Axium INS DRG IPG$684
Intracept$474
PROCLAIM$444
Senza$369
GENERAL PAIN MANAGEMENT$353
Penta SCS Leads$278
SPRINT PNS System$255
PENTA$245
OPTABLATE$229
SPINEJACK$229

How this compares

$26,767 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.

See all anesthesiology providers in Michigan →

Medicare billing

Part B allowed, 2024

$124,925

Medicare patients

129

Services billed

3,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	49	$951
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	42	$734
Pregabalin	28	$501
Gabapentin	39	$431
Amitriptyline Hcl	15	$123
Lorazepam	36	$20

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Marshall

Neal DuggalAnn Arbor$206K
John PappasRoyal Oak$112K
Jay GlobersonSouthfield$79K
David HovordAnn Arbor$48K
Birgete WebbGrosse Pointe Park$28K
Matthew McCordLansing$25K
Zachary WeinermanDetroit$24K
Bryan TomaRoyal Oak$22K
Patrick McKearneyGrand Rapids$21K
Richard BurkeTraverse City$17K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →